| 000 | 01163cam a22003138i 4500 | ||
|---|---|---|---|
| 001 | 83651 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102111949.0 | ||
| 008 | 160825t2016 flu b 001 0 eng d | ||
| 020 | _a9781498743471 | ||
| 040 |
_aDNLM/DLC _cDLC _erda _dES-MaUEC _dUEM |
||
| 050 | 4 |
_aRS380 _b.N53 2016 |
|
| 050 | 0 | 0 | _aRS380 |
| 082 | 0 | 0 | _a338.4/76151 |
| 100 | 1 |
_aNiazi, Sarfaraz, _d1949- _0Local _996168 |
|
| 245 | 1 | 0 |
_aBiosimilars and interchangeable biologics : _bstrategic elements _cSarfaraz K. Niazi |
| 260 |
_aBoca Raton _bCRC Press/Taylor & Francis _ccop. 2016 |
||
| 300 |
_axlv, 599 páginas _c29 cm |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_asin mediación _bn _2rdamedia |
||
| 338 |
_avolumen _bnc _2rdacarrier |
||
| 504 | _aIncluye referencias bibliográficas e índice | ||
| 650 | 7 |
_aBiotecnología farmacéutica _9155839 _0comprobar BNE19996549239 _2embne |
|
| 901 | _ai9781498743471 | ||
| 907 |
_a.b1292636x _b10-11-17 _c13-07-16 |
||
| 942 |
_2lcc _cM1S |
||
| 998 |
_am _a_vill _b25-08-16 _cm _da _ea _feng _gflu _h0 |
||
| 945 |
_aRS380 .N53 2016 _g1 _i930127494X _j0 _lmcg _o- _pEUR0.00 _q- _r- _s- _t1 _u1 _v1 _w1 _x0 _y.i11224642 _z25-08-16 |
||
| 999 |
_c83651 _d83651 |
||